Evidence map›Paper›PMID 41418933›Full record

ArticleJournal of the American Academy of Child and Adolescent Psychiatry2026

Nonfatal Drug Overdose in a National Sample of Adolescents by Intent and Substance, Medicaid 2016-2020.

Greta Bushnell, Mark Olfson, Diane P Calello, Kristen Lloyd, Yuyang Zhu, Hillary Samples

Abstract read
In one paragraph

Article in Journal of the American Academy of Child and Adolescent Psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Greta BushnellRutgers University, New Brunswick, New Jersey. Electronic address: greta.bushnell@rutgers.edu.
Mark OlfsonColumbia University, New York, New York.
Diane P CalelloRutgers University, New Brunswick, New Jersey.
Kristen LloydRutgers University, New Brunswick, New Jersey.
Yuyang ZhuRutgers University, New Brunswick, New Jersey.
Hillary SamplesRutgers University, New Brunswick, New Jersey.

Funding

ADHD and Sleep: Evaluating the Impact of Drug-Drug and Drug-Disease Interactions to Inform CareR01MH135875 · NIMH · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Greta Bushnell · 2025 to 2026
$1.3M
Benzodiazepine-related harms in young people: Informing policy, interventions, and prescribingK01DA050769 · NIDA · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI BUSHNELL, GRETA · 2021 to 2025
$1.0M
Multi-level associations between opioid use and overdose: Individual, clinical, and population-based risk factors for fatalityK01DA049950 · NIDA · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI SAMPLES, HILLARY · 2020 to 2024
$981k
Informing national overdose prevention and treatment strategies for high-risk adolescentsR21DA062273 · NIDA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI BUSHNELL, GRETA, SAMPLES, HILLARY · 2024 to 2024
$432k
NIDA NIH HHS K01 DA049950NIDA NIH HHS K01 DA050769NIDA NIH HHS R21 DA062273NIMH NIH HHS R01 MH135875
6 · The paper itself

Abstract

objectiveTo estimate the prevalence and patterns of drug overdoses in adolescents presenting to an inpatient or emergency department setting by substance and intent in a national sample of Medicaid enrollees.

methodNational Medicaid administrative claims data covering publicly insured adolescent (12-18 years old) enrollees from 2016 to 2020 were analyzed. Drug overdose was defined by an inpatient or emergency department poisoning code (ICD-10-CM T36-T50) for intentional, unintentional, or undetermined intent. Per calendar year, we estimated the prevalence of adolescents with a drug overdose among all eligible adolescent enrollees (≥10 months enrollment) overall and by patient demographics, intent, and substance involvement.

resultsThe annual sample of eligible adolescents ranged from 8.9 million (2016) to 10.9 million (2020). The average annual prevalence of any treated drug overdose was 0.41%, with minimal variation from 2016 (0.42%) to 2020 (0.40%). Prevalence varied by intent (intentional: 0.28%; unintentional: 0.17%, undetermined: 0.04%), sex, age, race and ethnicity, and, foster care status. Among adolescents with any intentional overdose claim, nonopioid analgesics (35.7%), antidepressants (21.6%), antipsychotics (9.8%), benzodiazepines (4.9%), and antiepileptics and other sedatives (6.0%) were most commonly involved. Cannabis (9.3%), benzodiazepines (8.4%), opioids (6.1%), and stimulants (5.2%) were more often involved in adolescents with any unintentional overdose claim. From 2016 to 2020, unintentional overdoses increased involving opioids (from 0.009% to 0.015%) and cannabis (from 0.012% to 0.017%).

conclusionWhile the prevalence of treated drug overdose was relatively stable from 2016 to 2020 among adolescent Medicaid enrollees, important patterns by substance, intent, and demographics were identified that will be key to reducing overdose morbidity and mortality in this young population. PLAIN LANGUAGE SUMMARY: This national study of adolescents enrolled in Medicaid estimated the annual prevalence of treated nonfatal drug overdose to be 0.41%, which varied by intent (0.28% intentional, 0.17% unintentional) and enrollee demographics. From 2016 to 2020, unintentional overdoses increased involving opioids (from 0.009% to 0.015%) and cannabis (from 0.012% to 0.017%). These patterns could potentially inform efforts to reduce adolescent overdose mortality.

Indexed as

Drug OverdoseMedicaidSubstance-Related DisordersAdolescentChildEmergency Room VisitsEmergency Service, HospitalFemaleHumansMalePrevalenceSuicide, AttemptedUnited Statesadolescentdrug overdoseMedicaidpoisoningsuicide

Identifiers

PMID41418933
PMCPMC13232535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.